Page 37 - Dan Budwick News Today : Breaking News, Live Updates & Top Stories | Vimarsana

RTW Participates in $95 Million Financing Round in Monte Rosa Therapeutics RTW Venture Fund Limited (the "Company"), the London Stock Exchange-listed investment company focused on identifying transformative assets with high growth potential across the life sciences sector, is pleased to note the announcement by Monte Rosa Therapeutics, Inc. ("Monte Rosa") on 12 March 2021 of its completion of a $95 million Series C financing round. The Company, alongside other investment vehicles of RTW Investments, LP (the "Investment Manager"), confirms that it participated in the financing rou...

(1) Centessa Pharmaceuticals ("Centessa"), a pharmaceutical company consisting of 10 subsidiary companies advancing a portfolio of high conviction programs with strong biological validation, today announced key additions to its leadership team. Gregory Weinhoff, M.D., MBA, joined the team as chief financial officer, while Mary Lynne Hedley, Ph.D., Robert M. Califf, M.D., MACC, and Samarth Kulkarni, Ph.D., joined Centessa's board of directors effective February 23, 2021. "Centessa launched last month with a goal of redefining pharmaceutical R&D productivity through an asset-centric model that ...

Alector Reports 2020 Fourth Quarter and Full Year Financial Results and Provides Business Update Continued execution across broad immuno-neurology portfolio, multiple milestones expected in 2021 Initiated AL001 INFRONT-3 Phase 3 trial in people with frontotemporal dementia with a progranulin mutation; pipeline expansion to ALS planned for 2021 Initiated AL002 INVOKE-2 Phase 2 trial in early Alzheimer’s disease patients Completed enrollment in the AL003 Phase 1 trial in Alzheimer’s disease patients. Strong balance sheet continues to support execution of clinical, research and operational ...

Posted on 370 Day One Biopharmaceuticals, a clinical-stage biopharmaceutical company focused on accelerating new, promising targeted therapies for children and adults with cancer, today announced the appointment of Charles N. York II as chief operating and financial officer and the addition of Natalie Holles to the Company’s board of directors. “Charles and Natalie are accomplished biopharmaceutical executives and bring significant financial, operational and corporate development expertise to Day One,” said Jeremy Bender, Ph....

Press release content from Business Wire. The AP news staff was not involved in its creation. Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences February 16, 2021 GMT BOSTON--(BUSINESS WIRE)--Feb 16, 2021-- Monte Rosa Therapeutics, a biotechnology company focused on discovering and developing precision medicines that degrade disease-causing proteins, announced today that leadership will participate in four upcoming virtual investor conferences, as follows: SVB Leerink Partners 10 th Annual Global Healthcare Conference – Tuesday, February 23, 2021 Cowen 40 th Annual Heal...